# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001558370-24-002241
Filing Date
2024-03-01
Accepted
2024-03-01 09:16:05
Documents
50
Period of Report
2024-03-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | glyc-20240301x8k.htm iXBRL | 8-K | 41763
2 | EX-99.1 | glyc-20240301xex99d1.htm | EX-99.1 | 53512
3 | GRAPHIC | glyc-20240301xex99d1g001.jpg | GRAPHIC | 203135
4 | GRAPHIC | glyc-20240301xex99d1g002.jpg | GRAPHIC | 207432
5 | GRAPHIC | glyc-20240301xex99d1g003.jpg | GRAPHIC | 159781
6 | GRAPHIC | glyc-20240301xex99d1g004.jpg | GRAPHIC | 142330
7 | GRAPHIC | glyc-20240301xex99d1g005.jpg | GRAPHIC | 153668
8 | GRAPHIC | glyc-20240301xex99d1g006.jpg | GRAPHIC | 103488
9 | GRAPHIC | glyc-20240301xex99d1g007.jpg | GRAPHIC | 183222
10 | GRAPHIC | glyc-20240301xex99d1g008.jpg | GRAPHIC | 151908
11 | GRAPHIC | glyc-20240301xex99d1g009.jpg | GRAPHIC | 149832
12 | GRAPHIC | glyc-20240301xex99d1g010.jpg | GRAPHIC | 137255
13 | GRAPHIC | glyc-20240301xex99d1g011.jpg | GRAPHIC | 145430
14 | GRAPHIC | glyc-20240301xex99d1g012.jpg | GRAPHIC | 145900
15 | GRAPHIC | glyc-20240301xex99d1g013.jpg | GRAPHIC | 144851
16 | GRAPHIC | glyc-20240301xex99d1g014.jpg | GRAPHIC | 150000
17 | GRAPHIC | glyc-20240301xex99d1g015.jpg | GRAPHIC | 158617
18 | GRAPHIC | glyc-20240301xex99d1g016.jpg | GRAPHIC | 117301
19 | GRAPHIC | glyc-20240301xex99d1g017.jpg | GRAPHIC | 148141
20 | GRAPHIC | glyc-20240301xex99d1g018.jpg | GRAPHIC | 139356
21 | GRAPHIC | glyc-20240301xex99d1g019.jpg | GRAPHIC | 152672
22 | GRAPHIC | glyc-20240301xex99d1g020.jpg | GRAPHIC | 149337
23 | GRAPHIC | glyc-20240301xex99d1g021.jpg | GRAPHIC | 121031
24 | GRAPHIC | glyc-20240301xex99d1g022.jpg | GRAPHIC | 145524
25 | GRAPHIC | glyc-20240301xex99d1g023.jpg | GRAPHIC | 147297
26 | GRAPHIC | glyc-20240301xex99d1g024.jpg | GRAPHIC | 213135
27 | GRAPHIC | glyc-20240301xex99d1g025.jpg | GRAPHIC | 179479
28 | GRAPHIC | glyc-20240301xex99d1g026.jpg | GRAPHIC | 203516
29 | GRAPHIC | glyc-20240301xex99d1g027.jpg | GRAPHIC | 184681
30 | GRAPHIC | glyc-20240301xex99d1g028.jpg | GRAPHIC | 167468
31 | GRAPHIC | glyc-20240301xex99d1g029.jpg | GRAPHIC | 171394
32 | GRAPHIC | glyc-20240301xex99d1g030.jpg | GRAPHIC | 179683
33 | GRAPHIC | glyc-20240301xex99d1g031.jpg | GRAPHIC | 123688
34 | GRAPHIC | glyc-20240301xex99d1g032.jpg | GRAPHIC | 119135
35 | GRAPHIC | glyc-20240301xex99d1g033.jpg | GRAPHIC | 159864
36 | GRAPHIC | glyc-20240301xex99d1g034.jpg | GRAPHIC | 125546
| Complete submission text file | 0001558370-24-002241.txt |  | 7605692

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
37 | EX-101.SCH | glyc-20240301.xsd | EX-101.SCH | 3800
38 | EX-101.LAB | glyc-20240301_lab.xml | EX-101.LAB | 1355
39 | EX-101.PRE | glyc-20240301_pre.xml | EX-101.PRE | 10724
51 | EXTRACTED XBRL INSTANCE DOCUMENT | glyc-20240301x8k_htm.xml | XML | 4612

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 24707236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)